Seeing Is Believing
Currently out of the existing stock ratings of David Stanton, 4 are a BUY (100%).
Analyst David Stanton works at JEFFERIES with a stock forecast success ratio of 66.67% fulfilled within 617 days on average.
David Stanton’s has documented 7 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MESO, Mesoblast Ltd at 31-Aug-2023.
Analyst best performing recommendations are on MESO (MESOBLAST LTD).
The best stock recommendation documented was for MESO (MESOBLAST LTD) at 1/19/2021. The price target of $2.24 was fulfilled within 527 days with a profit of $7.21 (76.3%) receiving and performance score of 1.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
0.85
8 months ago
2/3 (66.67%)
$-2.55 (-75.00%)
617
Buy
23
8 months 1 days ago
1/2 (50%)
$15.82 (220.33%)
64
Hold
18
8 months 25 days ago
5/5 (100%)
$1.08 (6.38%)
54
Sell
1.5
$-4.74 (-75.96%)
2
8 months 28 days ago
5/6 (83.33%)
$-1.78 (-54.27%)
305
Hold
2
$-4.24 (-67.95%)
8 months 28 days ago
1/1 (100%)
$-1.28 (-39.02%)
129
What Year was the first public recommendation made by David Stanton?